Claygent
Claygent is an AI agent developed by Clay, designed to support digital research tasks by visiting specified websites and summarizing relevant information. It allows users to ask about business nature (for instance, whether companies are B2B), compliance matters (such as SOC-II compliance), competition between entities, and more.
Product Demo Video
Distribution Score: 84/100 What is this? ⓘ
What is Claygent?
Claygent is an AI research agent integrated within the Clay data enrichment and go-to-market platform, automating the prospect research process by browsing the web, extracting specific information from company websites, and synthesizing findings into structured enrichment data.
Users define what information they need about prospects, and Claygent autonomously conducts the research for each record in a list.
The agent's web browsing capability enables it to find information that isn't in standard data providers' databases specific technologies mentioned in blog posts, hiring signals from job listings, recent product launches from press releases, or specific contact details from company leadership pages.
This flexibility to retrieve custom information from any publicly accessible web source gives Claygent unique research capabilities compared to traditional enrichment databases.
Sales teams using Clay for outbound prospecting, growth marketers building enriched audience segments, and revenue operations teams standardizing prospect data quality use Claygent to automate the research work that SDRs previously did manually before personalized outreach.
The automation of research tasks that consumed hours per batch of prospects enables sales teams to reach more prospects with better-personalized outreach simultaneously a productivity combination that manual processes can't achieve.
Who is Claygent for?
Learn this stack in Academy
Get implementation playbooks for tools like Claygent in guided Academy lessons. Start free, then unlock the full library with Learner.
Open Academy →Pricing & Access
Pricing details on provider page.
Alternatives to
Comments (0)
Sign in to join the discussion.